Acinetobacter baumannii Biyofilmi: Rol Oynayan Faktörler, Persistans, İlaç Direnci ve Tedavi Stratejileri

Pour NK, Dusane DH, Dhakephalkar PK, Zamin FR, Zinjarde SS, Chopade BA. Biofilm formation by Acinetobacter baumannii strains isolated from urinary tract infection and urinary catheters. FEMS Immunol Med Microbiol. 2011;62:328-38.

Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev. 2008;21:538-82.

Bergogne-Berezin E, Joly-Guillou M-L, Towner KJ. Acinetobacter: microbiology, epidemiology, infections, management. CRC press, 1995.

Bergogne-Berezin E, Towner K. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996;9:148.

Joly-Guillou M-L. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11:868-73.

Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J. Multistate point-prevalence survey of health care–associated infections. N Engl J Med. 2014;370:1198-208.

Lob SH, Hoban DJ, Sahm DF, Badal RE. Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii. Int J Antimicrob Agents. 2016;47:317-23.

Rodríguez‐Baño J, Marti S, Soto S, Fernández‐Cuenca F, Cisneros JM, Pachón J, Pascual A, Martínez‐Martínez L, McQueary C, Actis L. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect. 2008;14:276-8.

Jawad A, Seifert H, Snelling A, Heritage J, Hawkey P. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol. 1998;36:1938-41.

Wendt C, Dietze B, Dietz E, Rüden H. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol. 1997;35:1394-7.

Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002;15:167-93.

Francolini I, Donelli G. Prevention and control of biofilm-based medical-device-related infections. FEMS Immunol Med Microbiol. 2010;59:227-38.

Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Rafiq M, Kamil MA. Bacterial biofilm and associated infections. J Chinese Med Assoc. 2018;81:7-11.

Batoni G, Maisetta G, Esin S. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta 2016;1858:1044-60.

Parsek MR, Singh PK. Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003;57:677-701.

Greene C, Vadlamudi G, Newton D, Foxman B, Xi C. The influence of biofilm formation and multidrug resistance on environmental survival of clinical and environmental isolates of Acinetobacter baumannii. Am J Infect Control. 2016;44:e65-e71.

Gurung J, Khyriem AB, Banik A, Lyngdoh WV, Choudhury B, Bhattacharyya P. Association of biofilm production with multidrug resistance among clinical isolates of Acinetobacter baumannii and Pseudomonas aeruginosa from intensive care unit. Indian J Crit Care Med. 2013;17:214.

Tomaras AP, Dorsey CW, Edelmann RE, Actis LA. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology. 2003;149:3473-84.

Cevahir N, Demir M, Kaleli I, Gurbuz M, Tikvesli S. Evaluation of biofilm production, gelatinase activity, and mannose-resistant hemagglutination in Acinetobacter baumannii strains. J Microbiol Immunol Infect. 2008;41:513-8.

Lee JC, Koerten H, Van den Broek P, Beekhuizen H, Wolterbeek R, Van den Barselaar M, Van der Reijden T, Van der Meer J, Van de Gevel J, Dijkshoorn L. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol. 2006;157:360-6.

Gaddy JA, Tomaras AP, Actis LA. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun. 2009;77:3150-60.

Martí S, Rodríguez-Baño J, Catel-Ferreira M, Jouenne T, Vila J, Seifert H, Dé E. Biofilm formation at the solid-liquid and air-liquid interfaces by Acinetobacter species. BMC Res Notes. 2011;4:5.

Bardbari AM, Arabestani MR, Karami M, Keramat F, Alikhani MY, Bagheri KP. Correlation between ability of biofilm formation with their responsible genes and MDR patterns in clinical and environmental Acinetobacter baumannii isolates. Microb Pathog. 2017;108:122-8.

Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol. 2009;4:273_8.

Ivanković T, Goić-Barišić I, Hrenović J. Reduced susceptibility to disinfectants of Acinetobacter baumannii biofilms on glass and ceramic. Arhiv za higijenu rada i toksikologiju. 2017;68:99-107.

Kaliterna V, Kaliterna M, Hrenović J, Barišić Z, Tonkić M, Goic-Barisic I. Acinetobacter baumannii in Southern Croatia: clonal lineages, biofilm formation, and resistance patterns. Infect Dis. 2015;47:902-7.

Rumbo-Feal S, Gómez MJ, Gayoso C, Álvarez-Fraga L, Cabral MP, Aransay AM, Rodríguez-Ezpeleta N, Fullaondo A, Valle J, Tomás M. Whole transcriptome analysis of Acinetobacter baumannii assessed by RNA-sequencing reveals different mRNA expression profiles in biofilm compared to planktonic cells. PloS one. 2013;8:e72968.

Loehfelm TW, Luke NR, Campagnari AA. Identification and characterization of an Acinetobacter baumannii biofilm-associated protein. J Bacteriol. 2008;190:1036-44.

Han A, Li X, Huang B, Tsoi JK-H, Matinlinna JP, Chen Z, Deng DM. The effect of titanium implant surface modification on the dynamic process of initial microbial adhesion and biofilm formation. Int J Adhesion Adhesives. 2016;69:125-32.

Brossard KA, Campagnari AA. The Acinetobacter baumannii biofilm-associated protein plays a role in adherence to human epithelial cells. Infect Immun. 2012;80:228-33.

Proft T, Baker E. Pili in Gram-negative and Gram-positive bacteria—structure, assembly and their role in disease. Cell Mol Life Sci. 2009;66:613.

Gohl O, Friedrich A, Hoppert M, Averhoff B. The thin pili of Acinetobacter sp. strain BD413 mediate adhesion to biotic and abiotic surfaces. Appl Environ Microbiol. 2006;72:1394-401.

Harding CM, Hennon SW, Feldman MF. Uncovering the mechanisms of Acinetobacter baumannii virulence. Nat Rev Microbiol. 2018;16:91.

Shin J-H, Lee H-W, Kim S-M, Kim J. Proteomic analysis of Acinetobacter baumannii in biofilm and planktonic growth mode. J Microbiol. 2009;47:728-35.

de Breij A, Gaddy J, van der Meer J, Koning R, Koster A, van den Broek P, Actis L, Nibbering P, Dijkshoorn L. CsuA/BABCDE-dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC 19606 to human airway epithelial cells and their inflammatory response. Res Microbiol. 2009;160:213-8.

Kishii K, Hamada M, Aoki K, Ito K, Onodera J, Ishii Y, Tateda K. Differences in biofilm formation and transcription of biofilm-associated genes among Acinetobacter baumannii clinical strains belonging to the international clone II lineage. J Infect Chemother. 2020.

Wright M, Iovleva A, Jacobs M, Bonomo R, Adams M. Genome dynamics of multidrug-resistant Acinetobacter baumannii during infection and treatmen. Genome Med. 2016;8(1):26.

Choi AH, Slamti L, Avci FY, Pier GB, Maira-Litrán T. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-β-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol. 2009;191:5953-63.

Xiang J, Sun Z, Yang X, Huan J. Changes in expression of gene aba I in biofilm of Acinetobacter baumannii strains isolated from burn patients. Chin J Burns. 2012;28:101-5.

Bentancor LV, O’Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T. Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect Immun. 2012;80:651-6.

Roca Subirà I, Espinal P, Vila-Farrés X, Vila Estapé J. The Acinetobacter baumannii Oxymoron: Commensal Hospital Dweller Turned Pan-Drug-Resistant Menace. Front Microbiol. 2012;3.

Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, Hyun SH, Kim SA, Lee S-K, Lee JC. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol. 2005;7:1127-38.

Longo F, Vuotto C, Donelli G. Biofilm formation in Acinetobacter baumannii. New Microbiol. 2014;37:119-27.

Choi CH, Lee JS, Lee YC, Park TI, Lee JC. Acinetobacter baumannii invades epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiology. 2008;8:216.

Lee H-W, Koh YM, Kim J, Lee J-C, Lee Y-C, Seol S-Y, Cho D-T, Kim J. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect. 2008;14:49-54.

Rao RS, Karthika RU, Singh S, Shashikala P, Kanungo R, Jayachandran S, Prashanth K. Correlation between biofilm production and multiple drug resistance in imipenem resistant clinical isolates of Acinetobacter baumannii. Indian J Med Microbiol. 2008;26:333.

Diggle SP, Griffin AS, Campbell GS, West SA. Cooperation and conflict in quorum-sensing bacterial populations. Nature. 2007;450:411.

Uroz S, Dessaux Y, Oger P. Quorum Sensing and Quorum Quenching: The Yin and Yang of Bacterial Communication. Chem Biol Chem. 2009;10:205-16.

Bassler BL. Small talk: cell-to-cell communication in bacteria. Cell. 2002;109:421-4.

Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria. Annu Rev Cell Dev Biol. 2005;21:319-46.

Whitehead NA, Barnard AML, Slater H, Simpson NJL, Salmond GPC. Quorum-sensing in Gram-negative bacteria. FEMS Microbiol Rev. 2001;25:365-404.

Bhargava N, Sharma P, Capalash N. Quorum sensing in Acinetobacter: an emerging pathogen. Crit Rev Microbiol. 2010;36:349-60.

Kalia VC. Quorum sensing vs quorum quenching: a battle with no end in sight. Springer, 2015.

Anbazhagan D, Mansor M, Yan GOS, Yusof MYM, Hassan H, Sekaran SD. Detection of quorum sensing signal molecules and identification of an autoinducer synthase gene among biofilm forming clinical isolates of Acinetobacter spp. PloS one. 2012;7:e36696.

Guo H, Xiang J. Influences of abaR gene on biofilm formation of Acinetobacter baumannii. Chin J Burns. 2017;33:200-5.

Luo L-m, Wu L-j, Xiao Y-l, Zhao D, Chen Z-x, Kang M, Zhang Q, Xie Y. Enhancing pili assembly and biofilm formation in Acinetobacter baumannii ATCC 19606 using non-native acyl-homoserine lactones. BMC microbiology. 2015;15:62.

Saipriya K, Swathi C, Ratnakar K, Sritharan V. Quorum‐sensing system in Acinetobacter baumannii: a potential target for new drug development. J Appl Microbiol. 2020;128:15-27.

Greene C, Wu J, Rickard AH, Xi C. Evaluation of the ability of Acinetobacter baumannii to form biofilms on six different biomedical relevant surfaces. Lett Appl Microbiol. 2016;63:233-9.

Jones DS, Gorman SP. Medical Device Composition and Biological Secretion Influences on Biofilm Formation. Biofilms, Infection, and Antimicrobial Therapy: CRC Press, 2005:62-81.

Gilmore BF, Gorman SP. Antimicrobial devices. Russell, Hugo & Ayliffe’s: Principles and Practice of Disinfection, Preservation and Sterilization. 2013:500-13.

Nath N, Hyun J, Ma H, Chilkoti A. Surface engineering strategies for control of protein and cell interactions. Surface Sci. 2004;570:98-110.

Pamuła E, De Cupere V, Dufrêne YF, Rouxhet PG. Nanoscale organization of adsorbed collagen: Influence of substrate hydrophobicity and adsorption time. J Colloid Interface Sci. 2004;271:80-91.

Azelmad K, Hamadi F, Mimouni R, Amzil K, Latrache H, Mabrouki M, El Boulani A. Adhesion of Staphylococcus aureus and Staphylococcus xylosus to materials commonly found in catering and domestic kitchens. Food Control. 2017;73:156-63.

Mittelman MW. Adhesion to biomaterials. Bacterial adhesion: molecular and ecological diversity New York: Wiley-Liss, Inc. 1996:89-127.

O’Toole G, Kaplan HB, Kolter R. Biofilm formation as microbial development. Annu Rev Microbiol. 2000;54:49-79.

De Silva PM, Chong P, Fernando DM, Westmacott G, Kumar A. Effect of incubation temperature on antibiotic resistance and virulence factors of Acinetobacter baumannii ATCC 17978. Antimicrob Agents Chemother. 2018;62:e01514-17.

Eze EC, El Zowalaty ME. Combined Effects Of Low Incubation Temperature, Minimal Growth Medium, And Low Hydrodynamics Optimize Acinetobacter baumannii Biofilm Formation. Infect Drug Resistance. 2019;12:3523.

Mussi MA, Gaddy JA, Cabruja M, Arivett BA, Viale AM, Rasia R, Actis LA. The opportunistic human pathogen Acinetobacter baumannii senses and responds to light. J Bacteriol. 2010;192:6336-45.

Spormann A. Physiology of microbes in biofilms. Bacterial biofilms: Springer, 2008:17-36.

Martinez LR, Casadevall A. Cryptococcus neoformans biofilm formation depends on surface support and carbon source and reduces fungal cell susceptibility to heat, cold, and UV light. Appl Environ Microbiol. 2007;73:4592-601.

Nucleo E, Steffanoni L, Fugazza G, Migliavacca R, Giacobone E, Navarra A, Pagani L, Landini P. Growth in glucose-based medium and exposure to subinhibitory concentrations of imipenem induce biofilm formation in a multidrug-resistant clinical isolate of Acinetobacter baumannii. BMC Microbiol. 2009;9:270.

Gentile V, Frangipani E, Bonchi C, Minandri F, Runci F, Visca P. Iron and Acinetobacter baumannii biofilm formation. Pathogens. 2014;3:704-19.

Nwugo CC, Arivett BA, Zimbler DL, Gaddy JA, Richards AM, Actis LA. Effect of ethanol on differential protein production and expression of potential virulence functions in the opportunistic pathogen Acinetobacter baumannii. PLoS One. 2012;7:e51936.

Decré DJRFdL. Acinetobacter baumannii et résistance aux antibiotiques: un modèle d’adaptation. REVUE FRANCOPHONE DES LABORATOIRES. 2012;2012:43-52.

Bocanegra-Ibarias P, Pena-López C, Camacho-Ortiz A, Llaca-Díaz J, Silva-Sánchez J, Barrios H, Garza-Ramos U, Rodríguez-Flores AM, Garza-González E. Genetic characterisation of drug resistance and clonal dynamics of Acinetobacter baumannii in a hospital setting in Mexico. Int J Antimicrob agents. 2015;45:309-13.

El-Shazly S, Dashti A, Vali L, Bolaris M, Ibrahim ASJIJoID. Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii. Int J Infect Dis. 2015;41:42-9.

Laktib A, Hassi M, Hamadi F, Mimouni R, Bourouache M, Bihadassen B, Alla AA. Identification and antibiotic resistance of nosocomial bacteria isolated from the hospital environment of two intensive care units. Moroccan J Biol. 2018.

Eliopoulos GM, Maragakis LL, Perl TMJCid. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Antimicrob Resist. 2008;46:1254-63.

García-Garmendia J-L, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez F-J, Pérez-Paredes C, Barrero-Almodóvar AE, Miner MG. Risk factors for Acinetobacter baumannii nosocomial bacteremia in critically ill patients: a cohort study. Clin Infect Dis. 2001;33:939-46.

Azizi O, Shakibaie MR, Modarresi F, Shahcheraghi F. Molecular detection of class-D OXA carbapenemase genes in biofilm and non-biofilm forming clinical isolates of Acinetobacter baumannii. Jundishapur J Microbiol. 2015;8.

Safari M, Saidijam M, Bahador A, Jafari R, Alikhani MYJJorihs. High prevalence of multidrug resistance and metallo-beta-lactamase (MβL) producing Acinetobacter baumannii isolated from patients in ICU wards, Hamadan, Iran. J Res Health Sci. 2013;13:162-7.

Manchanda V, Sanchaita S, Singh N. Multidrug resistant Acinetobacter. J Glob Infect Dis 2: 291–304. 2010.

Babapour E, Haddadi A, Mirnejad R, Angaji S-A, Amirmozafari N. Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance. Asian Pac J Trop Med Biomed. 2016;6:528-33.

Rahbar MR, Rasooli I, Gargari SLM, Amani J, Fattahian Y. In silico analysis of antibody triggering biofilm associated protein in Acinetobacter baumannii. J Theor Biol. 2010;266:275-90.

Nahar A, Anwar S, Miah MRA. Association of biofilm formation with antimicrobial resistance among the Acinetobacter species in a tertiary care hospital in Bangladesh. J Med. 2013;14:28-32.

Badave GK, Kulkarni D. Biofilm producing multidrug resistant Acinetobacter baumannii: an emerging challenge. J clin diagn res. 2015;9:DC08.

Alav I, Sutton JM, Rahman KM. Role of bacterial efflux pumps in biofilm formation. J Antimicrob Chemother. 2018;73:2003-20.

He X, Lu F, Yuan F, Jiang D, Zhao P, Zhu J, Cheng H, Cao J, Lu G. Biofilm formation caused by clinical Acinetobacter baumannii isolates is associated with overexpression of the AdeFGH efflux pump. Antimicrob Agents Chemother. 2015;59:4817-25.

Chen H, Cao J, Zhou C, Liu H, Zhang X, Zhou T. Biofilm formation restrained by subinhibitory concentrations of tigecyclin in Acinetobacter baumannii is associated with downregulation of efflux pumps. Chemotherapy. 2017;62:128-33.

Sharma A, Sharma R, Bhattacharyya T, Bhando T, Pathania R. Fosfomycin resistance in Acinetobacter baumannii is mediated by efflux through a major facilitator superfamily (MFS) transporter—AbaF. J Antimicrob Chemotherap. 2016;72:68-74.

Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001;45:999-1007.

Young DM, Parke D, Ornston LN. Opportunities for genetic investigation afforded by Acinetobacter baylyi, a nutritionally versatile bacterial species that is highly competent for natural transformation. Annu Rev Microbiol. 2005;59:519-51.

Tanner WD, Atkinson RM, Goel RK, Toleman MA, Benson LS, Porucznik CA, VanDerslice JA. Horizontal transfer of the blaNDM-1 gene to Pseudomonas aeruginosa and Acinetobacter baumannii in biofilms. FEMS Microbiol Lett. 2017;364.

Grassi L, Maisetta G, Esin S, Batoni G. Combination strategies to enhance the efficacy of antimicrobial peptides against bacterial biofilms. Front Microbiol. 2017;8:2409.

Reffuveille F, de la Fuente-Núñez C, Mansour S, Hancock RE. A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother. 2014;58:5363-71.

Han X, Li Q, Shen L, Hu D, Qu Y. Correlation between the biofilm-forming ability, biofilm-related genes and antimicrobial resistance of Acinetobacter baumannii. Chin Crit Care Med. 2014;26:639-43.

Qi L, Li H, Zhang C, Liang B, Li J, Wang L, Du X, Liu X, Qiu S, Song H. Relationship between antibiotic resistance, biofilm formation, and biofilm-specific resistance in Acinetobacter baumannii. Frontiers in microbiology. 2016;7:483.

Yoon E-J, Chabane YN, Goussard S, Snesrud E, Courvalin P, Dé E, Grillot-Courvalin C. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii. MBio. 2015;6:e00309-15.

Khoury AE, Lam K, Ellis B, Costerton JW. Prevention and control of bacterial infections associated with medical devices. Am Soc Artif Intern Organs J. 1992;38:M174-8.

Roux A, Ghigo J-M. Les biofilms bactériens. Bulletin de l’Académie vétérinaire de France. 2006.

Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol. 2000;182:2675-9.

Ophir T, Gutnick DL. A role for exopolysaccharides in the protection of microorganisms from desiccation. Appl Environ Microbiol. 1994;60:740-5.

Espinal P, Marti S, Vila J. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect. 2012;80:56-60.

Fabre H. Contributions des propriétés physico-chimiques de surfaces de titane sur l’adhérence de microorganismes: application aux chambres implantables. Le Mans; 2017.

Roy R, Tiwari M, Donelli G, Tiwari V. Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action. Virulence. 2018;9:522-54.

Rybalchenko OV, Bondarenko VM, Orlova OG, Markov AG, Amasheh S. Inhibitory effects of Lactobacillus fermentum on microbial growth and biofilm formation. Arch Microbiol. 2015;197:1027-32.

Beganovic M, Luther MK, Daffinee KE, LaPlante KLJDm, disease i. Biofilm prevention concentrations (BPC) of minocycline compared to polymyxin B, meropenem, and amikacin against Acinetobacter baumannii. Diagn Microbiol Infect Dis. 2019;94:223-6.

Golberg K, Emuna N, Vinod T, Van Moppes D, Marks RS, Arad SM, Kushmaro A. Novel Anti‐Adhesive Biomaterial Patches: Preventing Biofilm with Metal Complex Films (MCF) Derived from a Microalgal Polysaccharide. Advanced Materials Interfaces. 2016;3:1500486.

Irani N, Basardeh E, Samiee F, Fateh A, Shooraj F, Rahimi A, Shahcheraghi F, Vaziri F, Masoumi M, Pazhouhandeh M. The inhibitory effect of the combination of two new peptides on biofilm formation by Acinetobacter baumannii. Microb Pathog. 2018;121:310-7.

Tiwari V, Tiwari D, Patel V, Tiwari M. Effect of secondary metabolite of Actinidia deliciosa on the biofilm and extra-cellular matrix components of Acinetobacter baumannii. Microb Pathog. 2017;110:345-51.

Shin D-S, Eom Y-BJAoM. Antimicrobial and antibiofilm activities of Clostridium butyricum supernatant against Acinetobacter baumannii. Archives Microbiol. 2020:1-10.

Rendueles O, Kaplan JB, Ghigo JM. Antibiofilm polysaccharides. Environ Microbiol. 2013;15:334-46.

Stewart P. Prospects for anti-biofilm pharmaceuticals. Pharmaceuticals. 2015;8:504-11.

Izano EA, Amarante MA, Kher WB, Kaplan JB. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms. Appl Environ Microbiol. 2008;74:470-6.

Kaplan JB. Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs. 2009;32:545-54.

Gawande PV, Clinton AP, LoVetri K, Yakandawala N, Rumbaugh KP, Madhyastha S. Antibiofilm efficacy of DispersinB® wound spray used in combination with a silver wound dressing. Microbiol insights. 2014;7:MBI. S13914.

Donelli G, Francolini I, Romoli D, Guaglianone E, Piozzi A, Ragunath C, Kaplan J. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes. Antimicrob Agents Chemother. 2007;51:2733-40.

Bouyahya A, Dakka N, Et-Touys A, Abrini J, Bakri Y. Medicinal plant products targeting quorum sensing for combating bacterial infections. Asian Pac J Trop Med. 2017;10:729-43.

Chow JY, Yang Y, Tay SB, Chua KL, Yew WS. Disruption of biofilm formation by the human pathogen Acinetobacter baumannii using engineered quorum-quenching lactonases. Antimicrob Agents Chemother. 2014;58:1802-5.

da Silva Trentin D, Giordani RB, Zimmer KR, Da Silva AG, Da Silva MV, dos Santos Correia MT, Baumvol IJR, Macedo AJ. Potential of medicinal plants from the Brazilian semi-arid region (Caatinga) against Staphylococcus epidermidis planktonic and biofilm lifestyles. J Ethnopharmacol. 2011;137:327-35.

Taganna JC, Quanico JP, Perono RMG, Amor EC, Rivera WL. Tannin-rich fraction from Terminalia catappa inhibits quorum sensing (QS) in Chromobacterium violaceum and the QS-controlled biofilm maturation and LasA staphylolytic activity in Pseudomonas aeruginosa. J Ethnopharmacol. 2011;134:865-71.

Givskov M, de Nys R, Manefield M, Gram L, Maximilien R, Eberl L, Molin S, Steinberg PD, Kjelleberg S. Eukaryotic interference with homoserine lactone-mediated prokaryotic signalling. J Bacteriol. 1996;178:6618-22.